Sid Singh - Feb 25, 2022 Form 4 Insider Report for EQUIFAX INC (EFX)

Role
President - USIS
Signature
/s/Lisa Stockard as Attorney-in-Fact
Stock symbol
EFX
Transactions as of
Feb 25, 2022
Transactions value $
-$1,653,976
Form type
4
Date filed
3/1/2022, 03:15 PM
Previous filing
Feb 24, 2022
Next filing
Jun 3, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EFX Common Stock Options Exercise $1.23M +8.87K +41.85% $138.45 30.1K Feb 25, 2022 Direct F1, F2
transaction EFX Common Stock Options Exercise $935K +7.34K +24.4% $127.37 37.4K Feb 25, 2022 Direct F1, F2
transaction EFX Common Stock Options Exercise $333K +3.01K +8.05% $110.76 40.4K Feb 25, 2022 Direct F1, F2
transaction EFX Common Stock Sale -$499K -2.33K -5.77% $214.09 38.1K Feb 25, 2022 Direct F1, F2, F3
transaction EFX Common Stock Sale -$731K -3.4K -8.92% $215.17 34.7K Feb 25, 2022 Direct F1, F2, F4
transaction EFX Common Stock Sale -$751K -3.46K -9.97% $217.11 31.2K Feb 25, 2022 Direct F1, F2, F5
transaction EFX Common Stock Sale -$2.17M -10K -32.13% $216.20 21.2K Feb 25, 2022 Direct F1, F2, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EFX Stock Option/Right to Buy Options Exercise $0 -3.01K -100% $0.00* 0 Feb 25, 2022 Common Stock 3.01K $110.76 Direct F1, F7
transaction EFX Stock Option/Right to Buy Options Exercise $0 -7.34K -100% $0.00* 0 Feb 25, 2022 Common Stock 7.34K $127.37 Direct F1
transaction EFX Stock Option/Right to Buy Options Exercise $0 -8.87K -100% $0.00* 0 Feb 25, 2022 Common Stock 8.87K $138.45 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in this Form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on 11/12/2021.
F2 Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date.
F3 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $213.60 to $214.575, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F4 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $214.61 to $215.60, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F5 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $216.66 to $217.49, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F6 The price reported in column 4 is a weighted average price. The shares were sold at prices ranging from $215.65 to $216.64, inclusive. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price will be provided.
F7 The option vests in three equal annual increments beginning 2/22/2020.